For the treatment of dwarfism, prevention of HIV-induced weight loss

For treatment of dwarfism, acromegaly and prevention of HIV-induced weight loss

Pegvisomant is a growth hormone receptor antagonist used for the treatment of acromegaly.

Used as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyrodism during the recovery phase of subacute thyroiditis.

May be used to treat primary, secondary or tertiary hypothyroidism. May also be used to suppress thyroid stimulating hormone (TSH) secretion in patients with simple (nontoxic) ...

For use in treatment of hypothyroidism.

Viêm mí mắt, kết mạc nhãn cầu, giác mạc, bán phần trước mắt đáp ứng với steroid.